Benefits of primary prophylaxis with letermovir in patients after allogeneic hematopoietic stem cell transplantation for hematologic malignancies
LMV as CMV primary prophylaxis has a beneficial effect on post HSCT outcome decreasing the incidence of severe aGVHD and cs-CMV reactivation.
Authors
- Martyna Włodarczyk (ORCID: https://orcid.org/0000-0002-3059-4175)
- Agata Wieczorkiewicz-Kabut
- Anna Kopińska (ORCID: https://orcid.org/0000-0002-6821-7033)
- Krzysztof Woźniczka
- Anna Armatys (ORCID: https://orcid.org/0000-0001-8537-5802)
- Patrycja Zielińska (ORCID: https://orcid.org/0000-0001-5215-5264)
- Izabela Noster
- Grzegorz Helbig (ORCID: https://orcid.org/0000-0003-3703-1268)
- Anna Koclęga (ORCID: https://orcid.org/0000-0001-7287-4485)
Institutions
- Medical University of Silesia (PL)
Publication Details
- Journal
- Expert Review of Hematology
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1080/17474086.2025.2509876
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00